Allspring Global Investments
RVNC

Allspring Global Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History

Allspring Global Investments’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,049
Closed -$15.8K – 2489
2024
Q3 		$15.8K Buy
+3,049
New +$15.2K ﹤0.01% 2044
2023
Q4 		– Sell
-4,424
Closed -$50.7K – 2807
2023
Q3 		$50.7K Sell
4,424
-1,126,937
-100% -$21.7M ﹤0.01% 2270
2023
Q2 		$28.6M Sell
1,131,361
-405,889
-26% -$12.6M 0.05% 503
2023
Q1 		$49.5M Buy
1,537,250
+442,726
+40% +$13.8M 0.08% 337
2022
Q4 		$20.2M Buy
1,094,524
+508,249
+87% +$11.6M 0.03% 585
2022
Q3 		$15.8M Buy
586,275
+585,888
+151,392% +$11.9M 0.03% 625
2022
Q2 		$5K Sell
387
-1,618
-81% -$24.9K ﹤0.01% 2617
2022
Q1 		$39K Buy
2,005
+130
+7% +$1.97K ﹤0.01% 2875
2021
Q4 		$30K Buy
+1,875
New +$31.3K ﹤0.01% 2885

Other funds holding RVNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Allspring Global Investments's RVNC Position: Q4 2024 in Review

Allspring Global Investments sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2024, closing a stake of 3,049 shares — an estimated $15.8K sold.

Allspring Global Investments first reported a position in RVNC in Q4 2021 and held it in 9 quarters. The position peaked at $49.5M in Q1 2023. 173 funds tracked by Wall St. Rank hold RVNC as of Q4 2024.

  • Allspring Global Investments reported no remaining Revance Therapeutics, Inc. position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 3,049 Revance Therapeutics, Inc. shares in Q4 2024, an estimated $15.8K.
  • Allspring Global Investments first reported a position in Revance Therapeutics, Inc. in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's Revance Therapeutics, Inc. position peaked at $49.5M in Q1 2023.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.